Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Nucleic Acid Detection Kit (Fluorescence PCR)

Intended for the qualitative detection of Middle East respiratory syndrome coronavirus (MERS-CoV) nucleic acid in nasopharyngeal swab specimens from patients suspected of having MERS.

SKU Code
AENE-RT031A
Approval
On request
Product Type
Assay / Kit
Status
Available

Intended for the qualitative detection of Middle East respiratory syndrome coronavirus (MERS-CoV) nucleic acid in nasopharyngeal swab specimens from patients suspected of having MERS.

Product typeAssay / Kit
Technology platformFluorescence PCR
Application areaRespiratory Infections

Epidemiology

Middle East respiratory syndrome coronavirus (MERS-CoV) is a β-coronavirus causing respiratory disease in humans, first identified on 24 July 2012 in a 60-year-old Saudi Arabian man who died. Clinical presentations range from asymptomatic or mild respiratory symptoms to severe acute respiratory illness and death.

Work Flow

Two recommended extraction procedures are available:

  • Option 1: Use a viral RNA extraction kit or a nucleic acid extraction/purification reagent.
  • Option 2: Use a general DNA/RNA extraction kit together with an automated nucleic acid extractor device.
SKU codeAENE-RT031A
Storage≤-18℃ In dark
Shelf-life9 months
Specimen TypeFreshly collected nasopharyngeal swabs
CV≤5.0%
Ct≤38
LoD1000 Copies/mL
SpecificityThere is no cross-reactivity with human coronaviruses human coronavirus SARSr-CoV and other common pathogens.
Applicable Instruments: Applied Biosystems 7500 Real-Time PCR Systems Applied Biosystems 7500 Fast Real-Time PCR Systems QuantStudio®5 Real-Time PCR Systems SLAN-96P Real-Time PCR Systems LightCycler®480 Real-Time PCR system LineGene 9600 Plus Real-Time PCR Detection System MA-6000 Real-Time Quantitative Thermal Cycler BioRad CFX96 Real-Time PCR System BioRad CFX Opus 96 Real-Time PCR System
ApprovalOn request
DocumentsDatasheet, IFU, SDS, COA / conformance, origin, and export documents where available

FAQ

What should be confirmed before quotation?

Sample context, collection method, and extraction workflow should be confirmed before final kit selection.

Which documents can be requested?

Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.

Can the format be adjusted for different workflows?

Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.

Send the essentials for a useful first reply.

Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-RT031A to the right quote or sample discussion.